September is prostate cancer awareness month. Women for prostate health supports women and their families affected by prostate cancer through education, public awareness, and prostate cancer screenings.
Picking up up momentum online, the #samadichallenge was started by robotic prostate surgeon, Dr. David Samadi to encourage women to have the men in their lives screened for prostate cancer. Dr. Samadi is a firm believer that the PSA test is the key to prostate cancer prevention.
Pushing September's Prostate Cancer Awareness Month, Dr. David Samadi has created the movement #samadichallenge. His challenge has called on all women to encourage the men in their lives to get screened for prostate cancer. A PSA test is one of the screening methods used to detect prostate cancer.
Prostate cancer expert and robotic prostate surgeon, Dr. David B. Samadi, talks about the importance of prostate cancer screening. With September being Prostate Cancer Awareness Month, Dr. Samadi is offering free prostate cancer screening including PSA test for prostate cancer prevention.
Robotic prostate surgeon and prostate cancer expert Dr. David Samadi, discusses a new test for prostate cancer screening, known as the prostate health index test. Dr. Samadi uses his own SMART surgery technique in the treatment of prostate cancer and has successfully treated over 5,600 prostate cancer patients.
A new study suggests low testosterone levels in low-risk prostate cancer patients could indicate a worsening condition. Robotic prostate surgeon and prostate cancer expert, Dr. Samadi weighs in on the discussion of prostate cancer treatment. Dr. Samadi recommends surgery as the best treatment for prostate cancer and to not fully trust biopsy results as they are random biopsies and are not 100% effective.
After a 23-year-long study, it has been concluded that prostate surgery at the time of a prostate cancer diagnosis, it the better choice over watchful waiting. Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital discussed the findings. Dr. Samadi has performed over 5,600 successful robotic prostate surgeries and stands behind the findings in the treatment of prostate cancer.
David B. Samadi, MD, robotic prostate surgeon and creator of the SMART (Samadi Modified Advanced Robotic Technique) Technique has brought minimally invasive robotic surgery to the Dominican Republic. The HOMS hospital is now home to the David Samadi Robotic Institute. With the opening of this facility, a greater level of prostate cancer treatment has been brought to the Caribbean.
World-renowned urologist and robotic prostate surgeon, Dr. David Samadi, talks about recent findings that would advance prostate cancer screening. While the PSA test is very useful in the detection of prostate cancer, it is not a cancer-specific test. This new test would be a more tailored, personalized screening that looks at a man's genes and determines the likelihood for prostate cancer.
New York prostate cancer surgeon and robotics expert, David B. Samadi, MD, joins the Today Show’s Matt Lauer and Al Roker to discuss the importance of prostate cancer screening and the PSA test. Dr. Samadi, Lauer’s long-time urologist, performs prostate exams - DREs (digital rectal exams) - on Matt and Al, demonstrating how quick and painless the test really is. In just 34 seconds Dr. Samadi can detect any irregularities in the prostate.
Following David B. Samadi, MD’s, appearance on the TODAY Show, Late Show with David Letterman added a humorous twist to the prostate cancer awareness message. Earlier in the week, Dr. Samadi, a New York prostate cancer expert, performed live digital rectal exams (DREs) on Matt Lauer and Al Roker, highlighting the quick pain-free process of prostate cancer screening. Dr. Samadi is a NY robotics expert and innovator in the field of prostate cancer diagnosis and robotic surgery.
David B. Samadi, MD’s, prostate exams made David Letterman’s Late Show Top Ten list. The list poked fun at the live, though not on-air, digital rectal exams (DREs) that Dr. Samadi performed on Matt Lauer and Al Roker. As an innovator in robotic surgery and a prostate cancer expert, Dr. Samadi was invited to participate in the TODAY Show segment highlighting prostate cancer awareness.
New York urologist and prostate cancer expert, Dr. David Samadi answers questions about seeing blood in your urine. The robotic prostate surgeon warns that it important to see a doctor if there is blood in your urine as it could indicate a bladder or kidney infection, or even bladder or kidney cancer. Blood in the urine could also result from an enlarged prostate.
With a recent recommendation reducing the frequency that women should have mammograms, Dr. Samadi, robotic surgeon and prostate cancer expert, discusses what these changes mean for patient care. Like the PSA test, regular mammograms increases the chance of detecting cancer at its early stages. Reducing the number of mammograms and PSA tests may save money, but Dr. Samadi asks, “what is the price of a life?”
New York prostate cancer surgeon and robotics expert, David B. Samadi, MD, joins the Today Show’s Matt Lauer and Al Roker to discuss the importance of prostate cancer screening and the PSA test. Dr. Samadi, Lauer’s long-time urologist, performs prostate exams - DREs (digital rectal exams) - on Matt and Al, demonstrating how quick and painless the test really is. In just 34 seconds Dr. Samadi can detect any irregularities in the prostate. Learn more about prostate cancer screening with David B. Samadi, MD at http://www.roboticoncology.com/
Ovarian cancer, a silent killer, is often diagnosed very late. New research suggests that ovarian cancer cells have a volatile smell that can be detected by dogs. Early diagnosis of ovarian cancer could significantly improve ovarian cancer survival rates. Dr. Samadi discusses similar studies where dogs detected melanoma and lung cancer, suggesting that they could be used to detect other cancers in the future.
Dr. Samadi says drinking 4 cups of coffee a day can help slow the growth of prostate cancer. Prostate cancer is a silent killer that affects 1 in 6 men; many are diagnosed in their 40’s. During the month of September – Prostate Cancer Awareness Month – Dr. Samadi is offering free second opinion reviews of PSA test results.
Dr. Samadi highlights the life-saving benefits of the PSA blood test. During September, National Prostate Cancer Awareness Month, Dr. Samadi and his team at the Lenox HIll Hospital Prostate Cancer Center are offering free consultations. Call 212-365-5000 to schedule a free, expert review of your PSA test results. During this segment, Dr. Samadi also stresses the important role that women play as health advocates.
Dr. Samadi highlights the most important tests for men as they age. In the 20s, men should have comprehensive annual physicals. By age 30 they should consider adding an EKG and chest x-ray to the annual physical. At age 40, men should have their first PSA test and prostate exam, and by age 50 a colonoscopy, testosterone check, and vitamin B12 check should be added. Individual risk factors should be discussed with your doctor. Screening should be tailored to the patient based on risk factors, including family history.
Men who eat a diet high in vegetable fat, such as nuts, avocados, and olive oil, may be less likely to have their prostate cancer spread. Dr. Samadi explains that researchers were able to identify a reduced risk of prostate cancer metastasis when men (who were already diagnosed with prostate cancer) consumed diets high in various types of vegetable fat.
Dr. Samadi explains the new AUA prostate cancer screening guidelines and how patients should interpret them. Overdiagnosis is a common concern about the PSA test, but Dr. Samadi points out that it shouldn't lead to overtreatment. Elevated PSA levels should be considered in the context of family history and other prostate cancer risk factors, under the guidance of a prostate cancer expert. Dr. Samadi addresses the new guidelines against testing younger men by citing the large volume of men in his own practice with advanced prostate cancer in their early 40s. Dr. Samadi encourages early testing, stating that 30% of prostate cancer cases prove understaged and undergraded in post-surgery analysis. Improved genetic screening and prostate cancer testing are needed, Dr. Samadi stresses.
Dr. David Samadi, world-renowned robotic prostate surgeon, provided free prostate cancer screenings at the Chian Foundation in Astoria, New York...
Dr. Samadi sites a recent study from the New England Journal of Medicine regarding a gene mutation that increases the patient's chances of developing prostate cancer. The test for the gene is simple and can be used to effectively identify whether a relative of someone diagnosed with prostate cancer may also be at risk. According to Samadi, such a test could be given to someone in their thirties who has older relatives with prostate cancer and the results could be used to to identify whether they were at risk.
Dr. David Samadi appears on Fox News to discuss a new study that's shed light on the benefits of multivitamins. Research indicates that taking a daily multivitamin can lower ones risk of cancer by 8% for men and women over 50 years of age.
Dr. Samadi appears on Fox Sunday House Call and discusses the new evidence supporting the value of PSA testing.
Prostate cancer treatment expert Dr. David Samadi gives men the gift of knowledge this Father's Day as he provides information about the importance of PSA testing and prostate cancer screening.
A federal panel has established new guidelines regarding prostate-specific antigen (PSA) screening for healthy men of all ages. Dr. David Samadi, prostate cancer expert; robotic prostatectomy surgeon; and PSA screening advocate, provides his opinion on this controversial new decision.
The PSA test is back on top this week, thanks to newly published University of Rochester Medical Center research supporting its life-saving benefits to men of all ages.
Dr. David Samadi highlights the importance of the PSA screening test and digital rectal exam (DRE) for prostate cancer. Many patients are symptom-free when diagnosed with prostate cancer. One of Dr. Samadi's patients and his wife speak about the life-saving benefits of the PSA test.
Prostate cancer expert Dr. David Samadi discusses a new observational study that shows that men who are circumcised at an early age may have a lower risk of developing prostate cancer later in life than those who are not.
A New prostate cancer study from Duke Cancer Institute found a significant increase in prostate cancer risk among men with heart disease. The study, originally designed to test the benign prostatic hyperplasia (BPH) drug Avodart for the prevention of prostate cancer, found a prostate cancer risk increase of 24% after two years with coronary artery disease. A staggering 74% increased risk was found after four years of heart disease in men.
Dr. Samadi, leading prostate cancer surgeon, continues to stress the importance and efficacy of prostate cancer PSA screening. Despite government health panel recommendations to the contrary, Dr. Samadi urges men to continue with annual PSA tests and discuss the results with their doctors, in conjunction with risk factor analyses.
Dr. Samadi, leading prostate cancer surgeon, continues to stress the importance and efficacy of prostate cancer PSA screening. Despite government health panel recommendations to the contrary, Dr. Samadi urges men to continue with annual PSA tests and discuss the results with their doctors, in conjunction with risk factor analyses. While not all elevated PSA levels indicate prostate cancer, Dr. Samadi believes the testing is invaluable in diagnosing prostate cancer. Acknowledging concerns over urinary and sexual function risks of surgery, he believes the medical community must concentrate efforts on improving surgical outcomes by bettering surgeon expertise.
Robotic prostatectomy surgeon, Dr. David Samadi, explains news about the potential and somewhat confusing link between birth control pills and prostate cancer. An observational study conducted by the British Medical Journal in Toronto found an increased incidence of deadly prostate cancer in countries where a significantly large number of women are taking oral contraception for long periods of time.
In further discussion about the controversial PSA test government guidelines, robotic prostatectomy surgeon, Dr. David Samadi reminds of the importance of personalized care in reviewing PSA levels. He encourages men to self-advocate by choosing a prostate specialist to monitor their PSA level changes from year to year. Dr. Samadi stresses the importance of establishing an early PSA baseline and then entrusting your prostate care to an expert, particularly following a prostate cancer diagnosis. Early detection and early treatment saves lives.
Dr. David Samadi, prostate cancer specialist at Mt. Sinai Medical Center, discusses prostate cancer key facts. He stresses the PSA test importance and the evaluation of test results by an experienced PSA expert to monitor PSA level trends and PSA velocity. Regarding alternative prostate cancer treatments, Dr. Samadi cautions against too much reliance on diet and supplements, but encourages men to maintain a healthy weight, exercise regularly and consume foods with antioxidants such as lycopene.
The controversial new recommendation against PSA screenings from a Department of Health task force has doctors speaking out. PSA testing has decreased prostate cancer mortality rates over the past 10-15 years, according to Dr. David Samadi, New York prostate cancer specialist at Mt. Sinai Medical Center. A colleague at nearby St. Luke’s-Roosevelt concurs – though the test is not perfect it is the best line of defense against prostate cancer.
Dr. David Samadi, Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, uses Prostate Cancer Awareness Month to share reminders about early screening and treatment options. Dr. Samadi stresses the importance of a PSA level baseline test at age 40, with annual follow-ups at age 45. For those men who are high-risk - African Americans, older men, and those with a family history - annual screening should begin earlier.
Dr. David Samadi stresses the importance of prostate cancer screening, stating that men over 50 years of age should get a PSA (Prostate Specific Antigen) test on an annual basis. Men with high risk factors for prostate cancer are advised to begin annual screening at the age of 40.
Dr. Samadi is featured on Fox and Friends to discuss robotic prostate surgery, prostate cancer screening tests, and new prostate cancer vaccine.
Man who drink coffee regularly can lower their risk of prostate cancer. The Harvard study found that the highest coffee drinkers had about 20% lower risk of regular cancer and a 60% of the deadliest form of the disease.
Dr. Samadi discusses his thoughts on a new study in the British Medical Journal that states that there is no benefit to prostate cancer screening.
Dr. Samadi urges prostate cancer screening as we near Fathers Day. Prostate cancer is a silent killer, with no symptoms whatsoever. But if it's caught early, prostate cancer has a 95% cure rate. Dr. Samadi's surgical experience along with the use of da Vinci technology not only cures patients, but also gives them a better quality of life by saving sexual function and urinary control.
Dr. David Samadi talks with his patient and prostate cancer survivor Ron and his wife Lyn about the importance of cancer screenings and knowing your risk factors. Ron makes note of knowing his aggressive family history and understanding the PSA Test.
The #samadichallenge is calling all women to encourage the men in their lives to get screened for prostate cancer. This Beverley Hills nurse is another woman that has accepted the #samadichallenge.
Accepting the #samadichallenge, another woman has urged all women to encourage their husbands and male family members to have a PSA test to prevent prostate cancer.
The Samadi Challenge acknowledges the vital role that women play in bringing an end to prostate cancer, the silent killer, through education, public awareness, and encouraging men to get regular health checkups and PSA screening tests.
Woman for Prostate Health is a support system for women and their families. The group helps women understand the importance of prostate cancer screening and prostate cancer treatment with robotic prostate surgery performed by Dr. David Samadi.
Taking the #samadichallenge, Kathy is another woman that pledges to help fight prostate cancer by getting all the men that she knows to get checked for prostate cancer.
The Samadi Challenge empowers women to get the men in their lives to schedule regular healthcare check ups and routine prostate cancer screening. Find out what you need to know about prostate cancer at www.roboticoncology.com.
The Prostate Cancer Awareness Challenge encourages women to take a proactive role in defeating prostate cancer, the silent killer, by encouraging men to live a healthy lifestyle and get regular prostate health screenings.
Another woman the is supporting the #samadichallenge, Arezou has vowed to take her husband to be screened for prostate cancer and has nominated others to do the same.
September is Prostate Cancer Awareness Month, to fight against prostate cancer robotic prostate surgeon Dr. David Samadi has started the #samadichallenge. The prostate cancer experts has challenged women to have the men in their lives screened for prostate cancer in order to fight the disease.
The #samadichallenge was started by NY robotic prostate surgeon Dr. David Samadi to get women involved in the fight against prostate cancer. Dr. Samadi has asked him to encourage the men in their lives to have a PSA test to detect prostate cancer and prevent further spreading of the cancer.
In an effort to prevent prostate cancer, Dr. David Samadi has created the #samadichallnge. Dr. Samadi is encouraging all women to have the men in their lives screened for prostate cancer with a PSA test.
Taking the #samadichallenge, another woman has vowed to take the men in their life to be screened for prostate cancer. The PSA test is the greatest tool in the fight against prostate cancer.